135 related articles for article (PubMed ID: 20100563)
41. NAT2 and CYP2E1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients.
An HR; Wu XQ; Wang ZY; Zhang JX; Liang Y
Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):535-43. PubMed ID: 22506592
[TBL] [Abstract][Full Text] [Related]
42. Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma.
Pellé L; Cipollini M; Tremmel R; Romei C; Figlioli G; Gemignani F; Melaiu O; De Santi C; Barone E; Elisei R; Seiser E; Innocenti F; Zanger UM; Landi S
Arch Toxicol; 2016 Dec; 90(12):3099-3109. PubMed ID: 26783003
[TBL] [Abstract][Full Text] [Related]
43. Associations between CYP1A1 and CYP2E1 polymorphisms and susceptibility to esophageal cancer in Chaoshan and Taihang areas of China.
Wang D; Su M; Tian D; Liang S; Zhang J
Cancer Epidemiol; 2012 Jun; 36(3):276-82. PubMed ID: 22088806
[TBL] [Abstract][Full Text] [Related]
44. Genetic polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the risk of advanced precancerous gastric lesions in a Chinese population.
You WC; Hong JY; Zhang L; Pan KF; Pee D; Li JY; Ma JL; Rothman N; Caporaso N; Fraumeni JF; Xu GW; Gail MH
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):451-8. PubMed ID: 15734972
[TBL] [Abstract][Full Text] [Related]
45. Association of CYP2E1 and NAT2 polymorphisms with lung cancer susceptibility among Mongolian and Han populations in the Inner Mongolian region.
Zhang JW; Yu WJ; Sheng XM; Chang FH; Bai TY; Lv XL; Wang G; Liu SZ
Asian Pac J Cancer Prev; 2014; 15(21):9203-10. PubMed ID: 25422202
[TBL] [Abstract][Full Text] [Related]
46. Screening for SNPs and haplotypes in the CYP3A7 gene in Chinese populations.
Du J; Shi Y; Zhang A; Wang L; Xuan J; He G; Xu L; Xu M; Shu A; Yu L; Li X; Meng J; Feng G; Xing Q; He L
Pharmacogenomics; 2007 Jun; 8(6):559-66. PubMed ID: 17559345
[TBL] [Abstract][Full Text] [Related]
47. Are polymorphisms in metabolism protective or a risk for reduced white blood cell counts in a Chinese population with low occupational benzene exposures?
Ye LL; Zhang GH; Huang JW; Li Y; Zheng GQ; Zhang DT; Zhou LF; Tao XD; Zhang J; Ye YJ; Sun P; Frank A; Xia ZL
Int J Occup Environ Health; 2015; 21(3):232-40. PubMed ID: 26179485
[TBL] [Abstract][Full Text] [Related]
48. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan.
Hildesheim A; Anderson LM; Chen CJ; Cheng YJ; Brinton LA; Daly AK; Reed CD; Chen IH; Caporaso NE; Hsu MM; Chen JY; Idle JR; Hoover RN; Yang CS; Chhabra SK
J Natl Cancer Inst; 1997 Aug; 89(16):1207-12. PubMed ID: 9274915
[TBL] [Abstract][Full Text] [Related]
49. CYP2E1 PstI polymorphism increases cervical neoplasia risk: a meta-analysis.
Wang X; He Y
Genet Mol Res; 2015 May; 14(2):5203-9. PubMed ID: 26125714
[TBL] [Abstract][Full Text] [Related]
50. [The relationship between the haplotype of T cells immunoglobulin mucin-3 gene and allergic asthma in the Han population from Hubei province of China].
Hu LH; Chen ZZ; Cui TP; Kong LL; Wang L; Chen FH
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Mar; 31(3):196-200. PubMed ID: 18785518
[TBL] [Abstract][Full Text] [Related]
51. Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese.
Stephens EA; Taylor JA; Kaplan N; Yang CH; Hsieh LL; Lucier GW; Bell DA
Pharmacogenetics; 1994 Aug; 4(4):185-92. PubMed ID: 7987402
[TBL] [Abstract][Full Text] [Related]
52. Association of the miR-146a, miR-149, miR-196a2 and miR-499 polymorphisms with susceptibility to pulmonary tuberculosis in the Chinese Uygur, Kazak and Southern Han populations.
Zhang X; Li Y; Li X; Zhang W; Pan Z; Wu F; Wang C; Chen Z; Jiang T; Xu D; Ping Z; Liu J; Liu C; Li Z; Li JC
BMC Infect Dis; 2015 Feb; 15():41. PubMed ID: 25650003
[TBL] [Abstract][Full Text] [Related]
53. Genetic variation of pharmacogenomic VIP variants in Zhuang nationality of southern China.
Liu Y; Li H; Cao K; Liu J; Sun Y; Wu J; Xiong Z; Niu F; Li J; Jin T
Pharmacogenomics J; 2021 Feb; 21(1):60-68. PubMed ID: 32699276
[TBL] [Abstract][Full Text] [Related]
54. Haplotype frequency distribution and linkage disequilibrium analysis of single nucleotide polymorphisms at the human FMO3 gene locus.
Hao DC; Sun J; Furnes B; Schlenk D; Hou ZF; Zhang YP; Yang SL; Yang L
Biochem Genet; 2006 Oct; 44(7-8):391-407. PubMed ID: 17096187
[TBL] [Abstract][Full Text] [Related]
55. A systematically combined genotype and functional combination analysis of CYP2E1, CYP2D6, CYP2C9, CYP2C19 in different geographic areas of mainland China--a basis for personalized therapy.
Wu Z; Zhang X; Shen L; Xiong Y; Wu X; Huo R; Wei Z; Cai L; Qi G; Xu Q; Cui D; Cui D; Zhao G; He L; Qin S
PLoS One; 2013; 8(10):e71934. PubMed ID: 24098323
[TBL] [Abstract][Full Text] [Related]
56. Clinical relevance of tag single nucleotide polymorphisms within the CAT gene in patients with PTSD in the Chongqing Han population.
Duan ZX; Li W; Kang JY; Zhang JY; Chen KJ; Li BC; He M; Wang JM
Int J Clin Exp Pathol; 2014; 7(4):1724-32. PubMed ID: 24817970
[TBL] [Abstract][Full Text] [Related]
57. Cytochrome P4502E1 genetic polymorphisms and lung cancer in a Taiwanese population.
Wang SL; Lee H; Chen KW; Tsai KJ; Chen CY; Lin P
Lung Cancer; 1999 Oct; 26(1):27-34. PubMed ID: 10574678
[TBL] [Abstract][Full Text] [Related]
58. N-acetyltransferase 2, cytochrome P4502E1 and glutathione S-transferase genotypes in antitubercular treatment-induced hepatotoxicity in North Indians.
Rana SV; Sharma SK; Ola RP; Kamboj JK; Malik A; Morya RK; Sinha SK
J Clin Pharm Ther; 2014 Feb; 39(1):91-6. PubMed ID: 24188272
[TBL] [Abstract][Full Text] [Related]
59. Pharmacogenetics of CYP1A2, novel polymorphisms and haplotypes in three distinct Asian populations.
Lim JS; Singh O; Ramasamy RD; Ramasamy S; Subramanian K; Lee EJ; Chowbay B
Drug Metab Pharmacokinet; 2010; 25(6):616-23. PubMed ID: 20930417
[TBL] [Abstract][Full Text] [Related]
60. Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population.
Hamdy SI; Hiratsuka M; Narahara K; El-Enany M; Moursi N; Ahmed MS; Mizugaki M
Br J Clin Pharmacol; 2002 Jun; 53(6):596-603. PubMed ID: 12047484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
